A new study from Harvard, presented last week at the American Heart Association meetings in Chicago, looked at 18,000 people admitted to the hospital with heart disease and followed them for over 6 years. The study found that adding the cholesterol-lowering drug Zetia to the standard statin drug simvastatin (the [...]